Court Denies J&J's Motion to Dismiss Pfizer's Complaint in Antitrust Suit

Court Denies J&J's Motion to Dismiss Pfizer's Complaint in Antitrust Suit


As we reported here , Pfizer filed an antitrust lawsuit last year against Johnson & Johnson in the U.S. District Court for the Eastern District of Pennsylvania alleging that J&J has engaged in an anticompetitive scheme to protect its Remicade product since Pfizer introduced its competing biosimilar Inflectra in 2016. As we reported here , on November 18, 2017, J&J filed a motion to dismiss Pfizer's complaint and on January 26, 2018, the Biosimilars Council filed an unopposed motion for leave to file an amicus curiae brief in opposition to J&J's motion to dismiss.



from Biotech News